KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oscar Health (OSCR) Non Operating Investment Income (2020 - 2023)

Oscar Health (OSCR) has disclosed Non Operating Investment Income for 4 consecutive years, with -$61000.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Non Operating Investment Income rose 91.98% year-over-year to -$61000.0, compared with a TTM value of -$831000.0 through Sep 2023, up 33.47%, and an annual FY2020 reading of $1.2 million, changed N/A over the prior year.
  • Non Operating Investment Income was -$61000.0 for Q3 2023 at Oscar Health, down from $34000.0 in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $654000.0 in Q1 2020 and bottomed at -$761000.0 in Q3 2022.
  • Average Non Operating Investment Income over 4 years is $13076.9, with a median of $34000.0 recorded in 2023.
  • The sharpest move saw Non Operating Investment Income surged 166.18% in 2021, then tumbled 3723.81% in 2022.
  • Year by year, Non Operating Investment Income stood at $303000.0 in 2020, then plummeted by 93.07% to $21000.0 in 2021, then crashed by 3723.81% to -$761000.0 in 2022, then surged by 91.98% to -$61000.0 in 2023.
  • Business Quant data shows Non Operating Investment Income for OSCR at -$61000.0 in Q3 2023, $34000.0 in Q2 2023, and -$43000.0 in Q1 2023.